Cos with coronavirus drugs, tests in development gain as outbreak spreads

Lakeland Industries

24/02/2020 12:11

** Shares of companies that have announced plans to develop
treatments, vaccines or diagnostic tests for the coronavirus
rise premarket 
    ** The virus has now killed more than 2,500 people in China,
and spread to about 28 countries and territories with a death
toll of around two dozen, fanning fears of a greater impact on
global growth 
    ** Shares of Gilead Sciences Inc  GILD.O , whose antiviral
remdesivir has shown promise in monkeys infected by a related
coronavirus, up 2.7% at $71.74 in active premarket trading 
    ** Vaccine developers Inovio Pharma  INO.O , Vaxart Inc
 VXRT.O , Novavax Inc  NVAX.O  rise between 12%-10% 
    ** Test maker Co-Diagnostics Inc's shares  CODX.O  rise
10.2% to $8.5; CODX up >50% since Jan. 23, after company
designed virus detection test 
    ** Shares of Lakeland Industrials  LAKE.O , which have risen
>20% since late Jan, up 13.2%; company makes protective clothing

 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709))